IL-15

IL-15 Overview

English NameInterleukin-15Approved Drugs0
Drugs in Clinical Trials22Target SynonymIL-15,Interleukin-15,IL15,Interleukin 15,MGC9721
Highest Development StagePhase 2 Clinical
English NameInterleukin-15
Target SynonymIL-15,Interleukin-15,IL15,Interleukin 15,MGC9721
Approved Drugs0
Drugs in Clinical Trials22
Highest Development StagePhase 2 Clinical

IL-15 Product List

  • Product Category

    Protein (13)Antibody (3)Kits (2)

  • Product Status

    Launched (18)

  • Species

    Human (11)Mouse (6)Cynomolgus / Rhesus macaque (1)

  • Tag

    Tag Free (5)Fc Tag & Avi Tag (2)Fc Tag (2)His Tag (3)His Tag & Avi Tag (1)Mouse IgG1 (3)- (2)

  • Conjugate

    Unconjugated (12)Biotin-labeled (3)- (2)PE Labeled (1)

Total: 18
  • 1
  • 2

IL-15 Background

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

IL-15 Synonyms

IL-15,Interleukin-15,MGC9721
  • Overview
  • Product List